The global veterinary pain management market size reached USD 1.6 Billion in 2024. Looking forward, the market is projected to reach USD 2.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.63% during 2025-2033. There are several factors that are driving the market, which include the rising number of pet parents, various regulatory approvals, and increasing prevalence of chronic diseases such as arthritis, cancer, joint pain, and post-surgical pain.
Veterinary pain management refers to various drugs and drug combinations administered to animals for providing relied from chronic pain. It involves the observation of behavioral cues and anticipating the type, severity and duration of the pain. The treatment involves physical compresses, massages, therapy, rehabilitation, acupuncture, laser therapy and the administration of therapeutic and antianxiety drugs. These drugs can be administered orally, parenterally or topically. Veterinary pain management involves implementing changes in housing conditions, diet and level of interaction with other animals and humans. It is effective against acute surgical, traumatic and disease-related pain and also aids in improving the overall health of the animal.
2. What is the expected growth rate of the global veterinary pain management market during 2025-2033?
3. What are the key factors driving the global veterinary pain management market?
4. What has been the impact of COVID-19 on the global veterinary pain management market?
5. What is the breakup of the global veterinary pain management market based on the product?
6. What is the breakup of the global veterinary pain management market based on the application?
7. What is the breakup of the global veterinary pain management market based on the end user?
8. What are the key regions in the global veterinary pain management market?
9. Who are the key players/companies in the global veterinary pain management market?
Veterinary pain management refers to various drugs and drug combinations administered to animals for providing relied from chronic pain. It involves the observation of behavioral cues and anticipating the type, severity and duration of the pain. The treatment involves physical compresses, massages, therapy, rehabilitation, acupuncture, laser therapy and the administration of therapeutic and antianxiety drugs. These drugs can be administered orally, parenterally or topically. Veterinary pain management involves implementing changes in housing conditions, diet and level of interaction with other animals and humans. It is effective against acute surgical, traumatic and disease-related pain and also aids in improving the overall health of the animal.
Veterinary Pain Management Market Trends:
The increasing domestication of animals, along with the rising awareness regarding pet health among the masses, is one of the key factors driving the growth of the market. Moreover, the convenient availability of pain management products and devices, including opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), laser devices and local anesthetics, is providing a thrust to the market growth. These solutions provide relief from the pain caused by musculoskeletal disorders, radiotherapy-induced pain, chemotherapy, osteoarthritis and mastitis. In line with this, the widespread adoption of laser therapy as an effective solution for pain management is also contributing to the market growth. Laser therapy provides significant pain-relief and also aids in regenerating nerve tissue post-surgery. Additionally, a significant increase in the livestock population suffering from cancer, abdominal and neuropathic pain is also creating a positive outlook for the market. Other factors, including the rising prevalence of inflammation and pain-causing diseases in domesticated animals, along with the widespread adoption of pet insurance services, are anticipated to drive the market toward growth.Market Segmentation:
This report provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. The report categorizes the market based on product, animal type, application, and end user.Breakup by Product:
- Drugs
- NSAIDs
- Anesthetics
- Opioids
- Other Drugs
- Devices
- Laser Therapy
- Electromagnetic Therapy
Breakup by Animal Type:
- Companion
- Livestock
Breakup by Application:
- Osteoarthritis and Joint Pain
- Postoperative Pain
- Cancer
- Others
Breakup by End User:
- Hospitals and Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Assisi Animal Health, Bayer AG, Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG), Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eli Lilly and Company, Idexx Laboratories Inc., Merck & Co. Inc., Norbrook, Vetoquinol S.A. and Zoetis Inc.Key Questions Answered in This Report
1. How big is the global veterinary pain management market?2. What is the expected growth rate of the global veterinary pain management market during 2025-2033?
3. What are the key factors driving the global veterinary pain management market?
4. What has been the impact of COVID-19 on the global veterinary pain management market?
5. What is the breakup of the global veterinary pain management market based on the product?
6. What is the breakup of the global veterinary pain management market based on the application?
7. What is the breakup of the global veterinary pain management market based on the end user?
8. What are the key regions in the global veterinary pain management market?
9. Who are the key players/companies in the global veterinary pain management market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Veterinary Pain Management Market
6 Market Breakup by Product
7 Market Breakup by Animal Type
8 Market Breakup by Application
9 Market Breakup by End User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Assisi Animal Health
- Bayer AG
- Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
- Ceva Sante Animale
- Chanelle Pharma
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company
- Idexx Laboratories Inc.
- Merck & Co. Inc.
- Norbrook
- Vetoquinol S.A.
- Zoetis Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 141 |
| Published | May 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 1.6 Billion |
| Forecasted Market Value ( USD | $ 2.7 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
